Detailseite
Projekt Druckansicht

Identifizierung therapeutischer Ziele eines alterierten Hippo-Signalweges im Leberkrebs

Fachliche Zuordnung Pathologie
Förderung Förderung von 2012 bis 2014
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 215611262
 
Erstellungsjahr 2015

Zusammenfassung der Projektergebnisse

The p53 tumor suppressor coordinates a series of anti-proliferative responses that restrict the expansion of malignant cells and, as a consequence, p53 is lost or mutated in the majority of human cancers. We could show that loss of p53 enables dedifferentiation of mature hepatocytes into nestin-positive progenitor-like cells, which are poised to differentiate into hepatocellular carcinomas (HCCs) or cholangiocarcinomas (CCs) in response to lineage-specific mutations that target Wnt and Notch signaling, respectively. Moreover, our results demonstrate that p53 restricts expression of the stem and progenitor cell-associated protein nestin in an Sp1/3 transcription factor-dependent manner and that nestin is required for tumor initiation in vivo. Therefore, we uncover an unexpected role for p53 dependent tumor suppression in restricting dedifferentiation of terminal differentiated cells.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung